Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2006;333:34-36 (1 July), doi:10.1136/bmj.333.7557.34
Graeme P Currie, specialist registrar, J Graham Douglas, consultant
Respiratory Unit, Aberdeen Royal Infirmary, Aberdeen.
| The first 150 words of the full text of this article appear below. |
Administering oxygen for chronic obstructive pulmonary disease (COPD) is not without risk and it should be properly prescribedin terms of flow rate and mode of deliverylike any other drug. Giving high concentrations of oxygen to hypoxaemic patients with hypercapnia can result in individuals losing their hypoxic drive to breathe, with development of CO2 retention, respiratory acidosis, and even death.
| |||||||||||
However, in acute and chronic ventilatory failure, oxygen supplementation is essential to maintain adequate delivery of oxyhaemoglobin to organs such as the heart, kidneys, and brain. Many patients who are chronically hypoxic are able to cope satisfactorily with an oxygen saturation of arterial blood of around 90%. However, at saturations below this, the oxygen dissociation curve rapidly steepens, and a sharp fall in oxygenated haemoglobin occurs with reduction in oxygen supply to vital organs.
| |||||||||||
Read all Rapid Responses